However, the very best candidate drug tested was the multi HDAC inhibitor panobinostat, which showed an extremely high tumor-suppressive effect throughout all HB models, while leaving healthy control cells unaffected (Fig. 1d). The gene discussed is HDAC9; the disease is hemoglobin measurement.